化学神经松解术在癌痛中的作用。
The role of chemical neurolysis in cancer pain.
机构信息
Department of Pain Medicine, The University of Texas MD Anderson Cancer Center, Houston, 77030, USA.
出版信息
Curr Pain Headache Rep. 2010 Aug;14(4):261-7. doi: 10.1007/s11916-010-0123-9.
Pain continues to be a significant symptom burden in cancer patients, with prevalence in 53% of patients at all stages of cancer and as high as 58% to 69% in those with advanced cancer. Neurolytic blocks are a mainstay in the armamentarium of cancer pain management, more so in intractable pain from advanced cancer. There is no clear consensus on patient selection, technique, or timing of these blocks. Here we discuss the use of various neurolytic blocks for cancer pain and detail some of the recent literature and our experience.
疼痛仍然是癌症患者的一个主要症状负担，在所有癌症阶段的患者中，疼痛的患病率为 53%，在晚期癌症患者中高达 58%至 69%。神经阻断术是癌症疼痛管理的主要手段，在晚期癌症的难治性疼痛中更是如此。对于这些阻断术的患者选择、技术和时机，目前尚无明确共识。在这里，我们讨论了各种神经阻断术在癌症疼痛中的应用，并详细介绍了一些最新的文献和我们的经验。
Zotero 插件